Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Singular Genomics Systems IncCommon Stock stock in Canada | $13.96

Own Singular Genomics Systems IncCommon Stock shares in just a few minutes.

Singular Genomics Systems Inc. Common Stock
NASDAQ: OMIC - USD
MEDICAL INSTRUMENTS & SUPPLIES
$13.96
+ $0.37 ( + 2.72%)

Singular Genomics Systems IncCommon Stock is a medical instruments & supplies business based in the US. Singular Genomics Systems IncCommon Stock stocks (OMIC.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $24.68 – a decrease of 1.2% over the previous week. Singular Genomics Systems IncCommon Stock employs 169 staff and has a market cap (total outstanding stock value) of $972.4 million.

How to buy shares in Singular Genomics Systems IncCommon Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OMIC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Singular Genomics Systems IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Singular Genomics Systems IncCommon Stock stock price

Use our graph to track the performance of OMIC stocks over time.

Singular Genomics Systems IncCommon Stock shares at a glance

Information last updated 2021-10-25.
Latest market close$13.96
52-week range$10.80 - $33.37
50-day moving average $13.26
200-day moving average $18.48
Wall St. target price$27.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.76

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
FREE TRADES
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get 2 free stocks when you open a Wealthsimple Trade personal account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
OFFER
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until December 31, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Singular Genomics Systems IncCommon Stock price performance over time

Historical closes compared with the close of $13.96 from 2021-10-25

1 week (2021-10-18) -1.20%
1 month (2021-09-24) 18.20%
3 months (2021-07-26) -19.77%
6 months (2021-04-22) N/A
1 year (2020-10-22) N/A
2 years (2019-10-22) N/A
3 years (2018-10-22) N/A
5 years (2016-10-22) N/A

Singular Genomics Systems IncCommon Stock financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $5.13
Market capitalisation $972.4 million

TTM: trailing 12 months

Shorting Singular Genomics Systems IncCommon Stock shares

There are currently 869,623 Singular Genomics Systems IncCommon Stock shares held short by investors – that's known as Singular Genomics Systems IncCommon Stock's "short interest". This figure is 27% up from 684,937 last month.

There are a few different ways that this level of interest in shorting Singular Genomics Systems IncCommon Stock shares can be evaluated.

Singular Genomics Systems IncCommon Stock's "short interest ratio" (SIR)

Singular Genomics Systems IncCommon Stock's "short interest ratio" (SIR) is the quantity of Singular Genomics Systems IncCommon Stock shares currently shorted divided by the average quantity of Singular Genomics Systems IncCommon Stock shares traded daily (recently around 194112.27678571). Singular Genomics Systems IncCommon Stock's SIR currently stands at 4.48. In other words for every 100,000 Singular Genomics Systems IncCommon Stock shares traded daily on the market, roughly 4480 shares are currently held short.

To gain some more context, you can compare Singular Genomics Systems IncCommon Stock's short interest ratio against those of similar companies.

However Singular Genomics Systems IncCommon Stock's short interest can also be evaluated against the total number of Singular Genomics Systems IncCommon Stock shares, or, against the total number of tradable Singular Genomics Systems IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Singular Genomics Systems IncCommon Stock's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Singular Genomics Systems IncCommon Stock shares in existence, roughly 10 shares are currently held short) or 0.0186% of the tradable shares (for every 100,000 tradable Singular Genomics Systems IncCommon Stock shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Singular Genomics Systems IncCommon Stock.

Singular Genomics Systems IncCommon Stock share dividends

We're not expecting Singular Genomics Systems IncCommon Stock to pay a dividend over the next 12 months.

Singular Genomics Systems IncCommon Stock overview

Singular Genomics Systems, Inc. , a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site